With this approach, we demonstrated that CD68+ and CD163+ cells appeared differentially distributed throughout morphologically distinct OS tumor regions—cellular rich osteolytic (OL) tumor regions and osteoid-matrix (OM) forming tumor regions poor in cellularity—supporting the hypothesis that these two cell types might exert different biological activities during OS development. The gene discussed is CD163; the disease is neoplasm.